Molekule Consulting (“Molekule”) is a recognized global leader in the development and refinement of primary competitive insights and intelligence for the biopharmaceutical and life sciences industries. Molekule aligns intelligence outcomes, focuses results and enables our client partners the ability to “win” in the highly dynamic and competitive biopharmaceutical space. Engaging with biopharmaceutical companies to provide accurate and actionable intelligence, Molekule Consulting remains a trusted partner of biopharmaceutical players today and tomorrow.
Lifescience Dynamics Limited is a specialist in primary human intelligence providing new intelligence – i.e. not known to our clients previously. Clients hire us to collect ‘high value intelligence’ which may impact on their strategic decisions. Our clients expect to receive “hard intelligence” which is not in the public domain, which is not written or published anywhere and certainly not available through any commercial databases.
Since 1992, trusted experts in primary regulatory, commercial and clinical CI research across 14 therapy areas and medical devices in N. America, Europe, APJ and LatAm – strong emerging market presence:
• Unique, best-in-class regulatory intelligence practice
• Systematic CI tracking programs
• Innovative competitor simulation workshops
• Strategic scenario planning workshops
• Strategic market opportunity/threat assessments
• Seasoned conference coverage methodologies
• Sensitive data leakage assessments & counter-intelligence seminars.
Atacana Group, Inc. is a new generation provider of competitive intelligence and strategy products for the pharmaceutical industry.
We deliver superior insights and a unique partnership by providing you with:
• A trusted cross-functional team with experience working in Pharma companies
• An innovative CI approach using Agile methodologies and digital tools
• A high-quality product through proven CI principles and processes
Our strength is managing large programs supporting:
• Potential blockbuster products that are in Phase 3 or that have recently launched
• Blockbuster products that are launching new indications
Our products include Ongoing Monitoring, Conference Insights, Deep Dives and CI Alerts.
AdisInsight is an easy-to-use database that helps you make better informed strategic decisions. A single search in the platform delivers highly-focused results from across the whole drug lifecycle allowing you to quickly see the big picture of a drug/disease landscape with interlinked information about drugs, trials, deals, safety and patents.
AlphaSense provides a revolutionary AI-based market intelligence search engine for corporations and investment firms. Our platform combines clients’ internal content with the world’s most valuable business and market information including broker research, call transcripts, company reports, news and trade journals. Seamlessly aggregating thousands of data sources, our groundbreaking semantic search engine captures variations in human language, accurately recognizing millions of business and financial terms and their synonyms, as well as companies, industries, topics and trends. Leveraging AlphaSense, corporations and financial firms make confident, quick decisions, enabling them to win in their markets. Used globally by more than 1,000 enterprise customers, AlphaSense is headquartered in New York with offices in London, Helsinki, India, and across the US.
CHR works exclusively with companies in the life science sector, from the world’s largest biopharmaceutical companies, through to one-asset start-ups, providing strategic decision support, action planning and competitive intelligence, in addition to tailored landscape analyses, commercial opportunity assessments, market modelling and product sales forecasting. Our evaluation of market-player activity, intent and capabilities, combined with a targeted understanding of key trends in prescriber, regulator, and payer environments, enables our clients to make key decisions from an optimally informed position.
Deallus is a unique strategic intelligence consultancy operating across the global life sciences sector. Our mission is simple: to prepare you for the future by delivering the forward-thinking assurance you need in an uncertain and highly competitive world. The knowledge and clarity we provide helps life sciences companies shape future markets by making the right strategic decisions with confidence.
Dig Worldwide is a specialist agency founded in 2011 providing back-to-basics primary competitive intelligence. We spend time talking to informed people rather than passively searching the internet and recycling information. Everything that Dig Worldwide does is based on asking the right questions of both our clients and potential sources of intelligence.
Evaluate provides trusted commercial intelligence for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present, and future of the global pharmaceutical market to drive better decisions. When you partner with Evaluate, our constantly expanding solutions and our transparent methodologies and datasets are instantly at your disposal, along with personalised, expert support.
Evaluate gives you the time and confidence to turn understanding into insight, and insight into action.
The Larvol Group, LLC provides innovative intelligence solutions to the pharmaceutical industry. Our reports offer customized weekly dashboards, news tracking, and other analytics within a given field. With over 120 professionals worldwide, we have expertise in all therapeutic areas including oncology, pain management, inflammation, CNS, cardiovascular disease and diabetes. Our clients include 9 of the top 10 pharmaceutical companies.
Intellar.com competitive intelligence dashboards from Perception Partners continuously curate the world’s most trusted strategic intelligence stories for IP, R&D and M&A. Based on more than 15 years of trained machine learning, NLP and AI, Intellar dashboards provide real-time summaries for executives while helping scientists and counsel efficiently link to underlying data – without the costly burdens of DIY data science.
At Prescient, science is at the core of everything we do. We are a biopharma product and portfolio strategy partner that specializes in turning the science of molecules into optimal patient outcomes and client value. Across therapeutic areas, we help develop winning strategies. When companies partner with us, a molecule in their hands has greater potential for success than the same science in the hands of their competitors.
Founded in 2007, Prescient is a partner with global reach and recognized capabilities, with six offices across three continents. Our team of more than 150 experts works with 22 of the top 25 biopharmaceutical companies, the fastest-growing mid-caps and cutting-edge emerging biotechs, including some of the biggest and most innovative brands. More than 80% of our employees hold advanced degrees, and our teams deliver an impressive depth of therapeutic, clinical and commercial expertise, a wealth of relevant experience and knowledge of best practices and common pitfalls.
Our two specialized businesses, Prescient Intelligence & Insight and Prescient Advisory, work independently or collaboratively depending on our clients’ needs to deliver on our mission and vision.
•Prescient Intelligence & Insight offers best-in-class biopharmaceutical intelligence by providing impactful insight and decision support to product and portfolio teams from early clinical
development through to loss of exclusivity.
•Prescient Advisory helps biopharmaceutical clients create clinical and commercial strategies that deliver differentiated and valuable brands. We support the development and execution of
asset strategy and brand plans by framing the sweet spot for your product, shaping your strategic decision making and activating your functional and regional strategies.
Prescient has been a portfolio company of Baird Capital since 2017. For more information, please visit: www.prescienthg.com.